T1	Participants 69 168	nausea, vomiting and appetite loss in remission induction chemotherapy of acute myeloid leukemia--a
T2	Participants 368 390	acute myeloid leukemia
T3	Participants 429 504	granisetron alone and combination with granisetron plus methylprednisolone.
T4	Participants 670 688	combination group.
T5	Participants 689 845	The single and combination groups comprised 14 and 13 patients, respectively, and there was no significant difference between the background of both groups.
